ArticleJournal of the National Cancer Institute2025

Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer.

Paolo Tarantino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.